Oncolytics Biotech ONCY
NASDAQ ONCY
$0.41 +0.03 (+7.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Oncolytics Biotech (ONCY) Share-based Compensation (IS) (2009 - 2011)

Updated

Oncolytics Biotech's Share-based Compensation (IS) was $148,983 in Q3 2019, up 15.8% from $128,647 a year earlier.

Analysis

Oncolytics Biotech (ONCY) Share-based Compensation (IS) (2009 - 2011) Analysis & Trends

On a trailing twelve-month basis, Oncolytics Biotech's Share-based Compensation (IS) was $1.31 million through Sep 30, 2019, up 76.3% year-over-year; for FY2011, it came in at $912,942.

  • In earlier years, Share-based Compensation (IS) was $1,675 in FY2010 (-99.6%) and $424,273 in FY2009.
  • Quarterly Share-based Compensation (IS) has moved between $91,690 (Q3 2017) and $680,541 (Q4 2018) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Oncolytics Biotech 47.36 Mn 23.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 912,942.00
Dec 31, 2010 1.50 Mn
Sep 30, 2010 5.59 Mn
Jun 30, 2010 5.20 Mn
Mar 31, 2010 5.19 Mn
Dec 31, 2009 396,110.00
Sep 30, 2009 7,982.00
Jun 30, 2009 8,544.00
Mar 31, 2009 11,637.00
API Access

Oncolytics Biotech Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ONCY&period=max&api_key=YOUR_API_KEY